Dr. Ahmed Chenna, Ph.D.
Dr. Chenna has over 25 years of experience in research, development, and the supervision of scientists, research associates, and graduate students in academia and biotechnology companies. Currently, Dr. Chenna is a principal scientist in the oncology group in Monogram Biosciences Inc., a part of the Laboratory Corporation of America, and managed the oncology reagent group. In the 1990s, he worked as Staff Scientist in the Lawrence Berkeley National Laboratory, Life Science Division, University of California at Berkeley and as postdoctoral research associate, in the Department of Pharmacological Sciences, School of Medicine, State University of New York at Stony Brook on DNA damage, repair and replication. Dr. Chenna was a co-principal investigator of two-awarded NIH sponsored research grants for $3.2 million. From 1986 to 1990, he was a Ph.D. student at Strathclyde University in Glasgow, Scotland, (UK), where he designed and synthesized a series of a novel compounds tested for their potential biological activity in the central nervous system (CNS) and anti-cancer by Organon Laboratories Ltd., UK. He is member of the American Chemical Society (ACS), and he served on the board of the Algerian American Association of Northern California (AAA-NC); he is also a member and one of the founders of the Algerian Competences Association (ACA). Dr. Chenna authored over 60 technical publications & conference abstracts including 13 US patents.